Dublin – 25th October, 2012 – The inaugural Global Bio Pharma Summit will take place at The Convention Centre Dublin on Wednesday 31st October, 2012.
Building on the proud history of Ireland’s Pharmaceutical Manufacturing Sector, it is intended to grow the summit as an annual platform for the Irish Diaspora working in the Global Pharma and Drug Development sector. An impartial platform, the summit will focus on the themes of ‘Maintaining Ireland’s Pharma Manufacturing Competitiveness Through Innovation’ and ‘Drug Delivery Research & Innovation’.
The conference will include a distinguished list of public and corporate speakers from across the Irish Pharmaceutical sector, including Pat O’Mahony, Chief Executive of the Irish Medicines Board; Dr. Ambrose McLoughlin, Secretary General of the Department of Health; Dr. Liam Tully, Director of the Pfizer Global Process Development Centre; John Kiernan, Vice President & Managing Director of Quintiles Ireland Limited; Frank Hallinan PhD, Biopharmaceutical Quality Consultant; Professor David Brayden BSc, MSC, PhD; Professor Ian Marison; Dr. Ena Prosser, Partner of Fountain Healthcare Partners; Barry O’Leary, CEO of IDA Ireland; Prof. Cormac Taylor of UCD Conway Institute; Dr. Ruth Freeman, Director at Enterprise & International Affairs Science Foundation Ireland; and Brian O’Neil, Manager of Lifesciences at Enterprise Ireland.
In attendance from the small molecule manufacturing sector are Site Leaders, Technical Leaders, Technical Services, General Managers, CEO’s & Managing Directors, and Suppliers. From the bio and drug development sector: R&D, Licensing, M&A, Finance and Business Development, Heads of Strategic Alliances, Market Analysts, Heads of Life Science, Policy Makers, Regulators, Academia and Legal and Financial Advisors.
The Summit is sponsored by Pfizer and supported by the Department of Health, the IDA, Enterprise Ireland, PharmaChemical Ireland, the IPHA, and the EUPHA.